A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
Status:
NOT_YET_RECRUITING
Trial end date:
2029-03-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of BG-75098 alone and in combination with BGB-43395 and fulvestrant in participants with advanced solid tumors.